Diplomat announces availability of Lilly’s Taltz

FLINT, Mich. — Diplomat Pharmacy announced Tuesday that it had been selected as part of Eli Lilly and Co.’s limited-distribution network for its recently approved plaque psoriasis treatment Taltz (ixekizumab). 

 

"Psoriasis is a serious chronic disease that can have debilitating symptoms," Diplomat president Gary Kadlec said. “Taltz enables patients an important treatment option.”

 

Information about Diplomat’s psoriasis program can be found here.